THEY STATE. I.- That on 6 may 1999, the Borrowers (which included the companies Huelva de Cable y Televisión, S.A., Cádiz de Cable y Televisión, S.A., Cable y Televisión de El Puerto, S.A., Cable y Televisión de Andalucía, S.A., Corporación Mallorquina de Cable, S.A., Albacete Sistemas de Cable, S.A., Santander de Cable, S.A. and TDC Sanlúcar, S.A. (even if Santander de Cable, S.A. and TDC Sanlúcar, S.A. became Borrowers on a subsequent date) which were absorbed by Cableuropa, the universal successor of all of the companies’ rights and obligations) and Ono Finance executed a subordinated multi-borrower credit facility (the “Original Facility”), whereby the Borrowers received from Ono Finance a facility for a maximum of 123,071,054.35 Euros, undertaking to pay to Ono Finance upon any payment or prepayment of principal made by the Borrowers under the Original Facility, apart from the principal, 1,928,945.65 Euros as a maintenance and repayment fee, the aggregate being 125,000,000.
THEY STATE. I.- That on 9 February 2001, the Borrowers (which at the time included the companies Huelva de Cable y Televisión, S.A., Cádiz de Cable y Televisión, S.A., Cable y Televisión de El Puerto, S.A., Cable y Televisión de Andalucía, S.A., Corporación Mallorquina de Cable, S.A., Albacete Sistemas de Cable, S.A., Santander de Cable, S.A. and TDC Sanlúcar, S.A., which were absorbed by Cableuropa, the universal successor of all of the companies’ rights and obligations) and Ono Finance executed a subordinated multi-borrower credit facility (the “Original Facility”), whereby the Borrowers received from Ono Finance a facility for a maximum of 129,305,259.10 Euros, undertaking to pay to Ono Finance upon any payment or prepayment of principal made by the Borrowers under the Original Facility, apart from the principal, 20,694,740.90 Euros as a maintenance and repayment fee, the aggregate being 150,000,000 Euros.
THEY STATE. That the SPONSOR is interested in carrying out the CLINICAL TRIAL described in the first clause of the Contract. That the CRO, as the SPONSOR’s representative, may make payments in its name. That the FOUNDATION, in accordance with the provisions of its Statutes, is attributed the role of developing research, innovation and managing knowhow, inspired by the principle of legality and the principles of ethics and professional conduct, which form a part of managing the clinical trials carried out at the HOSPITAL. Furthermore, the FOUNDATION, in accordance with the current entered into with SERMAS on 17 June 2009 has, amongst other commitments, the management of the clinical trials carried out at the HOSPITAL as the Resolution 227/2019 of the Dirección General de Planificación, Investigación y Formación de la Consejería xx Xxxxxxx de la Comunidad de Madrid with date on 22 April 2019. Based on the above statements, the PARTIES have decided to formalise this Contract, in accordance with the following:
THEY STATE. One: That they have decided to form a group, pursuant to the terms of Section 3.20 of Circular 2/2015 of 22 July, issued by the National Commission of Markets and Competition, establishing the gas system transmission network balancing regulations: Two: That for the purpose of complying with the terms of Clause 7 of the Framework Contract approved through the Decision of the National Commission of Markets and Competition dated xx xxxxx 2016, they have agreed to appoint as the Group's Manager User - 2
THEY STATE. That the SPONSOR is interested in conducting the CLINICAL STUDY described in the first clause of the Agreement. That the FOUNDATION’s purpose is to promote the scientific-technological investigation, as well as the training and teaching in the Area of Health Sciences, with the aim of bettering the quality of the assistance at the Hospital General Universitario Xxxxxxxx Xxxxxxx. The specific agreements between the Hospital and the Foundation, confer the latter the management and contracting of all the Clinical Studys that have been authorised by the relevant Ethics and Clinical Investigation Committee, the Foundation being the contracting party of the Clinical Studys. Based on the above, the parties decide to formalize this Agreement, according to the following:
THEY STATE. That the SPONSOR is interested in conducting the CLINICAL TRIAL described in the first clause of the Agreement. That the FOUNDATION, the “Servicio Madrileño de la Salud”, and the Agency “Xxxxx Xxxx Entralgo” for the teaching, research and sanitary studies of “Comunidad de Madrid” subscribed, on date 17 of June of 2009 an agreement for the managing and coordination of Biomedical Research conducted at the HOSPITAL. Based on the above, the parties decide to formalize this Agreement, according to the following:
THEY STATE. That Infodesain Technology, S. L has the right and responsibility to distribute IMTLazarus software in Spain and has the knowledge and infrastructure necessary to provide the service. - That aims to provide solutions in different sectors and to provide consulting services, assistance and infrastructure to companies. Both parties have decided to enter into this BUSINESS AGREEMENT, and therefore agree for the following CLAUSES
THEY STATE. That the SPONSOR is interested in carrying out the CLINICAL TRIALS described in the FIRST CLAUSE of the Contract.
THEY STATE. That the SPONSOR is interested in conducting the CLINICAL TRIAL described in the first clause of the Agreement. That in accordance with those explicated in the current Agreement signed on July 7th of 2004 between the INSALUD and the FOUNDATION, among other functions corresponds to the FOUNDATION the administration of the clinical trials that they are performed at University Hospital Puerta de Hierro. Additionally, the Agreement signed between the University Hospital Puerta de Hierro and the Foundation, on February 24th of 2005, ratifies that the clinical trials that are carried out into the different departments of the University Hospital Puerta de Hierro, should be contracted and executed by the FOUNDATION. Based on the above, the parties decide to formalize this Agreement, according to the following:
